Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEG-guided vs Preemptive TXA in Total Hip Replacement
NCT05956769Not yet recruiting
- Sponsor
- Konkuk University Medical Center
- Start
- Feb 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid (3 arms), sponsored by Konkuk University Medical Center. Primary endpoint: CRT maximal amplitude at 24 hours. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT05956769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05956769.